Atrial Arrhythmias in COVID-19 and Influenza

Published: 5 April 2022| Version 5 | DOI: 10.17632/rm6rjpft8j.5
Contributors:
,
,
,
,
,
,
,
,
,
,

Description

Data of 8,559 patients (6,927 COVID-19 and 1,632 influenza patients) who were admitted to the hospitals in Southeast Michigan. Patients were stratified into three groups based on the status of atrial arrhythmias (atrial fibrillation and atrial flutter). The retrospective timeframe is January 1, 2014 through December 31, 2019 for influenza patients and March 1, 2020 through March 31, 2021 for COVID-19 patients.

Files

Steps to reproduce

Retrospective data were obtained from the Epic, Inc. electronic medical record covering the time period between January 1, 2014, through May 31, 2021, for patients hospitalized with influenza virus and SARS-CoV-2 infection. Patients were stratified into three groups: Normal sinus rhythm, new-onset atrial arrhythmias, and history of arterial arrhythmias. A detailed chart review was performed, and data were collected on baseline demographics, comorbid conditions, social history, vital signs, laboratory values, chest computed tomography, transthoracic echocardiographic findings, pre-admission medications, in-hospital events, and in-hospital treatments. The study had approval as a retrospective study from Henry Ford Health System and Trinity Health institutional review boards. Statistical analyses were performed using R version 4.0.4. Reference: Jehangir Q, Lee Y, Latack K, et al. Incidence, Mortality, and Imaging Outcomes of Atrial Arrhythmias in COVID-19. American Journal of Cardiology. doi: 10.1016/j.amjcard.2022.02.051.

Institutions

Henry Ford Hospital, Saint Joseph Mercy Oakland Hospital

Categories

Electrophysiology, Influenza, Atrial Arrhythmia, Cardiology, COVID-19

Licence